Amicus to delay filing for US marketing rights for lead drug
Yahoo News (Reuters) - Amicus Therapeutics Inc said it was unlikely to submit a U.S. marketing application for its lead drug, to treat Fabry disease, by the end of 2015 as expected, after U.S. health regulators asked for a more comprehensive analysis of trial ... |
October 02, 2015 at 01:19PM | marketing - Google News
Amicus to delay filing for US marketing rights for lead drug - Yahoo News
marketing - Google News
Nenhum comentário:
Postar um comentário